These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6385952)

  • 21. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune endocrine diseases.
    De Baets MH
    Year Immunol; 1989; 4():264-75. PubMed ID: 2564710
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoimmune insulitis. Pathological findings in experimental animal models and juvenile diabetes mellitus.
    Egeberg J; Junker K; Kromann H; Nerup J
    Acta Endocrinol Suppl (Copenh); 1976; 205():129-37. PubMed ID: 793275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes.
    Casellas A; Salavert A; Agudo J; Ayuso E; Jimenez V; Moya M; Muñoz S; Franckhauser S; Bosch F
    Diabetes; 2006 Dec; 55(12):3246-55. PubMed ID: 17130467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulitis as a consequence of immune dysregulation: further evidence.
    Flohr K; Kiesel U; Freytag G; Kolb H
    Clin Exp Immunol; 1983 Sep; 53(3):605-13. PubMed ID: 6352097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Auto-immunity and insulin-dependent diabetes].
    Vialettes B; Beaume D; Vague P
    Diabete Metab; 1982 Dec; 8(4):349-55. PubMed ID: 6761189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 30. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental autoimmune diabetes: a new tool to study mechanisms and consequences of insulin-specific autoimmunity.
    Rajasalu T; Barth C; Spyrantis A; Durinovic-Belló I; Uibo R; Schirmbeck R; Boehm BO; Karges W
    Ann N Y Acad Sci; 2004 Dec; 1037():208-15. PubMed ID: 15699519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the pathogenesis of type 1 (insulin-dependent) diabetes mellitus: facts, areas still under development and new perspectives.
    Bottazzo GF; Bonifacio E; Wagner R; al-Sakkaf L; Dean BM; Mirakian R
    Klin Wochenschr; 1990; 68 Suppl 21():26-37. PubMed ID: 2198388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Insulin" induced insulitis.
    Klöppel G
    Acta Endocrinol Suppl (Copenh); 1976; 205():107-21. PubMed ID: 793273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin-dependent diabetes, an autoimmune disease].
    Hamburger J
    C R Acad Sci III; 1986; 303(8):299-301. PubMed ID: 3094847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-mediated immunity in type I (insulin-dependent) diabetes of man and the BB rat.
    Naji A; Silvers WK; Barker CF
    Concepts Immunopathol; 1985; 2():32-46. PubMed ID: 3916413
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin dependent diabetes mellitus as an autoimmune disease.
    Monos DS; Zmijewski CM
    In Vivo; 1988; 2(1):83-9. PubMed ID: 2979822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.